Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care, new data show.

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults combined, cancer is the second most common cause of death (after heart disease).

Researchers have identified a previously unknown inflammatory mechanism that may drive the aggressiveness and relapse of small cell lung cancer. Small cell lung cancer (SCLC) is among the most aggressive types of lung cancer and carries a five year survival rate of just five percent.

Add Yahoo as a preferred source to see more of our stories on Google. Cancer remains one of humanity's most formidable challenges, claiming the lives of millions every year despite decades of medical progress. While some cancers respond well to treatment ...

The five-year survival rate for all cancers combined in the US reached a landmark 70% for Americans diagnosed between 2015 and 2021 — yet three specific types are still causing an alarming number

Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of the disease. An experimental antibody targets a protein that fuels tumor growth and shuts down immune defenses,

The drug is not considered a cure, but results emerging from clinical trials point to the first major advancement in decades for a devastating cancer.

Brain, liver, lung, oesophagus, pancreas and stomach cancers receive just 18.9% of all government-funded cancer research.

Decoding the complex communication system of the deadliest brain cancer has revealed that an already approved HIV drug could be the key to treatment.